BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	11,556	14,902	-	-	-	-
Enterprise Value	11,294	15,314	-	-	-	-
Last Close Price	130.82	168.70	-	-	-	-
PE Ratio	19.29	33.33	-	-	-	-
Forward PE	-	22.57	-	-	-	-
PS Ratio	1.41	2.55	-	-	-	-
PB Ratio	2.31	3.20	-	-	-	-
P/TBV Ratio	2.31	3.20	-	-	-	-
P/OCF Ratio	16.18	49.71	-	-	-	-
EV/Sales Ratio	1.37	2.62	-	-	-	-
EV/EBITDA Ratio	8.95	16.53	-	-	-	-
EV/EBIT Ratio	11.50	20.85	-	-	-	-
Debt / Equity Ratio	0.33	0.37	0.94	1.32	0.96	0.61
Debt / EBITDA Ratio	1.29	1.86	2.96	8.59	6.45	1.42
Debt / FCF Ratio	4.88	-	4.24	-	-	-
Net Debt / Equity Ratio	-0.05	0.05	0.80	1.11	0.02	-0.26
Net Debt / EBITDA Ratio	-0.21	0.23	2.54	7.26	0.13	-0.61
Net Debt / FCF Ratio	-0.78	-7.19	3.63	-1.02	-0.04	1.03
Asset Turnover	0.89	0.83	0.64	0.36	0.41	0.87
Inventory Turnover	2.35	2.70	2.44	2.16	2.79	3.24
Quick Ratio	0.77	1.07	0.40	0.39	2.47	3.16
Current Ratio	1.71	2.36	1.17	1.13	3.21	4.19
Return on Equity (ROE)	12.71%	12.74%	17.79%	7.85%	18.65%	54.07%
Return on Assets (ROA)	6.66%	6.55%	7.71%	3.33%	4.08%	18.59%
Return on Invested Capital (ROIC)	11.96%	9.94%	11.18%	6.58%	14.48%	84.28%
Return on Capital Employed (ROCE)	14.50%	11.20%	16.00%	6.30%	6.50%	23.80%
Earnings Yield	5.18%	3.00%	-	-	-	-
FCF Yield	2.88%	-0.20%	-	-	-	-
Buyback Yield / Dilution	-28.87%	-27.79%	-	-0.01%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.